Skip to main content
OpenTrials

Clinical trial condition

IDH1 Mutation Myeloid Neoplasms

Explore clinical trials studying IDH1 Mutation Myeloid Neoplasms. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

IDH1 Mutation Myeloid Neoplasms trial results

Completed

IDH1 Inhibition Using Ivosidenib as Maintenance Therapy for IDH1-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation

NCT03564821

Conditions
IDH1 Mutation Myeloid Neoplasms
Locations
  • Johns Hopkins Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details